Pro rata valuation of physician samples upheld, and extended limitation rejected for lack of intent to evade duty.

Physician samples cleared from the same production as sale packs may be valued on a pro rata basis with reference to comparable sale packs under the valuation rules, and the addition of catch cover cost was not sustained. On the facts disclosed, there was no material showing wilful suppression or intent to evade duty, so invocation of the extended limitation period was unsustainable. The demand and penalties therefore could not survive.

---

---

Issues: (i) Whether physician samples cleared in catch covers were to be valued by including the cost of the catch covers or on the pro rata basis adopted from the sale pack; (ii) Whether invocation of the extended period was justified.

Issue (i): Whether physician samples cleared in catch covers were to be valued by including the cost of the catch covers or on the pro rata basis adopted from the sale pack.

Analysis: The valuation dispute concerned physician samples manufactured from the same goods cleared partly as sale packs and partly as samples. The appellant had valued the samples on a pro rata basis with reference to the sale pack, and the inclusion of catch cover cost was not shown to alter that basis. The prior decision in the appellant's own sister unit supported the same approach. The cited Supreme Court ruling was also understood as permitting valuation of physician samples on a pro rata basis with the aid of comparable goods and best judgment assessment under the valuation rules.

Conclusion: The valuation of physician samples on the pro rata basis was accepted and the addition of catch cover cost was not upheld.

Issue (ii): Whether invocation of the extended period was justified.

Analysis: The duty on physician samples had been discharged on a disclosed pro rata basis, and the only dispute was over non-inclusion of the catch cover value. On these facts, the record did not support a finding of wilful suppression or intent to evade duty. The basis for applying the longer limitation period was therefore not made out.

Conclusion: Invocation of the extended period was held to be unsustainable.

Final Conclusion: The demand and penalties could not survive, and the assessee obtained relief on both valuation and limitation.

Ratio Decidendi: Where physician samples are cleared from the same production and are valued on a pro rata basis with comparable sale packs, their valuation can be determined on that basis under the valuation rules, and extended limitation is unavailable in the absence of material showing intent to evade duty.

---